rs143611778

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_002024.6(FMR1):​c.375T>C​(p.Thr125Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000871 in 1,209,368 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 338 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00054 ( 0 hom., 17 hem., cov: 23)
Exomes 𝑓: 0.00090 ( 0 hom. 321 hem. )

Consequence

FMR1
NM_002024.6 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.746

Publications

1 publications found
Variant links:
Genes affected
FMR1 (HGNC:3775): (fragile X messenger ribonucleoprotein 1) The protein encoded by this gene binds RNA and is associated with polysomes. The encoded protein may be involved in mRNA trafficking from the nucleus to the cytoplasm. A trinucleotide repeat (CGG) in the 5' UTR is normally found at 6-53 copies, but an expansion to 55-230 repeats is the cause of fragile X syndrome. Expansion of the trinucleotide repeat may also cause one form of premature ovarian failure (POF1). Multiple alternatively spliced transcript variants that encode different protein isoforms and which are located in different cellular locations have been described for this gene. [provided by RefSeq, May 2010]
FMR1 Gene-Disease associations (from GenCC):
  • fragile X syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • fragile X-associated tremor/ataxia syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics
  • premature ovarian failure 1
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • symptomatic form of fragile X syndrome in female carrier
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant X-147928763-T-C is Benign according to our data. Variant chrX-147928763-T-C is described in ClinVar as Likely_benign. ClinVar VariationId is 286418.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.746 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000536 (60/112041) while in subpopulation AMR AF = 0.00104 (11/10570). AF 95% confidence interval is 0.000583. There are 0 homozygotes in GnomAd4. There are 17 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 17 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FMR1NM_002024.6 linkc.375T>C p.Thr125Thr synonymous_variant Exon 5 of 17 ENST00000370475.9 NP_002015.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FMR1ENST00000370475.9 linkc.375T>C p.Thr125Thr synonymous_variant Exon 5 of 17 1 NM_002024.6 ENSP00000359506.5

Frequencies

GnomAD3 genomes
AF:
0.000536
AC:
60
AN:
111987
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000162
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00104
Gnomad ASJ
AF:
0.000377
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000370
Gnomad FIN
AF:
0.000165
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000771
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000590
AC:
108
AN:
183138
AF XY:
0.000591
show subpopulations
Gnomad AFR exome
AF:
0.000228
Gnomad AMR exome
AF:
0.000438
Gnomad ASJ exome
AF:
0.000535
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000125
Gnomad NFE exome
AF:
0.000942
Gnomad OTH exome
AF:
0.000886
GnomAD4 exome
AF:
0.000905
AC:
993
AN:
1097327
Hom.:
0
Cov.:
29
AF XY:
0.000885
AC XY:
321
AN XY:
362827
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26373
American (AMR)
AF:
0.000710
AC:
25
AN:
35199
Ashkenazi Jewish (ASJ)
AF:
0.000568
AC:
11
AN:
19368
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30161
South Asian (SAS)
AF:
0.000333
AC:
18
AN:
54104
European-Finnish (FIN)
AF:
0.000568
AC:
23
AN:
40528
Middle Eastern (MID)
AF:
0.000242
AC:
1
AN:
4131
European-Non Finnish (NFE)
AF:
0.00105
AC:
880
AN:
841391
Other (OTH)
AF:
0.000738
AC:
34
AN:
46072
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
35
69
104
138
173
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000536
AC:
60
AN:
112041
Hom.:
0
Cov.:
23
AF XY:
0.000497
AC XY:
17
AN XY:
34207
show subpopulations
African (AFR)
AF:
0.000162
AC:
5
AN:
30862
American (AMR)
AF:
0.00104
AC:
11
AN:
10570
Ashkenazi Jewish (ASJ)
AF:
0.000377
AC:
1
AN:
2652
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3576
South Asian (SAS)
AF:
0.000372
AC:
1
AN:
2691
European-Finnish (FIN)
AF:
0.000165
AC:
1
AN:
6079
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
215
European-Non Finnish (NFE)
AF:
0.000771
AC:
41
AN:
53185
Other (OTH)
AF:
0.00
AC:
0
AN:
1524
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000982
Hom.:
6
Bravo
AF:
0.000752
EpiCase
AF:
0.000546
EpiControl
AF:
0.000889

ClinVar

Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Aug 05, 2016
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 13, 2016
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jun 14, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:1
Aug 01, 2021
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
9.0
DANN
Benign
0.70
PhyloP100
0.75
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143611778; hg19: chrX-147010281; API